Literature DB >> 31025898

Evaluation of the Pediatric Research Participation Questionnaire for Measuring Attitudes Toward Cancer Clinical Trials Among Adolescents and Young Adults.

Lamia P Barakat1,2, Evelyn Stevens1, Yimei Li1,2, Anne Reilly1,2, Janet A Deatrick3, Naomi E Goldstein4, Lisa A Schwartz1,2.   

Abstract

Purpose: Reasons for the relatively low rates of adolescent and young adults (AYA) enrollment in cancer clinical trials in the United States require further empirical examination. In addition to structural factors such as lack of access and insurance barriers, attitudes toward clinical trials may be important to consider. This study aimed to evaluate and validate the Pediatric Research Participation Questionnaire (PRPQ)-a measure of attitudes to clinical trials adapted for AYA (15-29) with cancer and their caregivers.
Methods: One hundred twenty-four AYA and 94 caregivers completed the PRPQ-AYA and measures of clinical trial knowledge and developmental/emotional maturity. Factor analysis evaluated the PRPQ-AYA structure, interitem reliability was computed, and Pearson correlations examined associations of validation measures with factor scores and computed scores reflecting perceived barriers, perceived benefits, and decision balance.
Results: Confirmatory factor analysis did not confirm the prior PRPQ factor structure. Exploratory factor analysis suggested a new four-factor structure for: AYA (1) trust/mistrust, (2) barriers/costs, (3) support for participation, and (4) incentives; and caregivers (1) trust/access, (2) mistrust/costs, (3) support for participation, and (4) risks to AYA. Factor scores and barriers, benefits, and decision balance scores demonstrated acceptable interitem reliability and were significantly correlated with clinical trial knowledge and emotional maturity in the expected direction.
Conclusion: PRPQ-AYA factor structure for AYA and caregivers varied and should be interpreted cautiously due to limited power. Simple solutions of perceived benefits, perceived barriers, and decision balance were reliable and valid and provide important information to address and engage AYA through the clinical trial informed consent process.

Entities:  

Keywords:  adolescent and young adults decision-making; attitudes toward cancer clinical trials; cancer clinical trials enrollment

Mesh:

Year:  2019        PMID: 31025898      PMCID: PMC8666797          DOI: 10.1089/jayao.2018.0144

Source DB:  PubMed          Journal:  J Adolesc Young Adult Oncol        ISSN: 2156-5333            Impact factor:   2.223


  42 in total

1.  The therapeutic orientation to clinical trials.

Authors:  Franklin G Miller; Donald L Rosenstein
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

Review 2.  Cancer in 15- to 29-year-olds by primary site.

Authors:  Archie Bleyer; Aaron Viny; Ronald Barr
Journal:  Oncologist       Date:  2006-06

Review 3.  Involving children and adolescents in medical decision making: developmental and clinical considerations.

Authors:  M A McCabe
Journal:  J Pediatr Psychol       Date:  1996-08

4.  The impact of disease severity on the informed consent process in clinical research.

Authors:  M H Schaeffer; D S Krantz; A Wichman; H Masur; E Reed; J K Vinicky
Journal:  Am J Med       Date:  1996-03       Impact factor: 4.965

5.  RTOG physician and research associate attitudes, beliefs and practices regarding clinical trials: implications for improving patient recruitment.

Authors:  Connie M Ulrich; Jennifer L James; Eleanor M Walker; Sharon Hartson Stine; Elizabeth Gore; Bradley Prestidge; Jeff Michalski; Clement K Gwede; Robert Chamberlain; Deborah Watkins Bruner
Journal:  Contemp Clin Trials       Date:  2010-03-06       Impact factor: 2.226

Review 6.  Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors.

Authors:  Edward J Mills; Dugald Seely; Beth Rachlis; Lauren Griffith; Ping Wu; Kumanan Wilson; Peter Ellis; James R Wright
Journal:  Lancet Oncol       Date:  2006-02       Impact factor: 41.316

7.  The role of adolescents in decisions concerning their cancer therapy.

Authors:  S Leikin
Journal:  Cancer       Date:  1993-05-15       Impact factor: 6.860

8.  Decision-making by adolescents and parents of children with cancer regarding health research participation.

Authors:  Kate Read; Conrad Vincent Fernandez; Jun Gao; Caron Strahlendorf; Albert Moghrabi; Rebecca Davis Pentz; Raymond Carlton Barfield; Justin Nathaniel Baker; Darcy Santor; Charles Weijer; Eric Kodish
Journal:  Pediatrics       Date:  2009-08-10       Impact factor: 7.124

9.  Will my child do better if she enrolls in a clinical trial?

Authors:  Malcolm A Smith; Steven Joffe
Journal:  Cancer       Date:  2018-10-06       Impact factor: 6.860

10.  Clinical Trial Decision Making in Pediatric Sickle Cell Disease: A Qualitative Study of Perceived Benefits and Barriers to Participation.

Authors:  Chavis A Patterson; Veronica Chavez; Valerie Mondestin; Janet Deatrick; Yimei Li; Lamia P Barakat
Journal:  J Pediatr Hematol Oncol       Date:  2015-08       Impact factor: 1.289

View more
  2 in total

1.  Parental decision making regarding consent to randomization on Children's Oncology Group AALL0932.

Authors:  Kellee Parker; Erika Cottrell; Linda Stork; Susan Lindemulder
Journal:  Pediatr Blood Cancer       Date:  2021-01-26       Impact factor: 3.167

2.  Conducting Psychosocial Intervention Research among Adolescents and Young Adults with Cancer: Lessons from the PRISM Randomized Clinical Trial.

Authors:  Abby R Rosenberg; Courtney C Junkins; Nicole Sherr; Samantha Scott; Victoria Klein; Krysta S Barton; Joyce P Yi-Frazier
Journal:  Children (Basel)       Date:  2019-10-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.